How Will You Manage the New 2018 DOT Drug Testing Mandates?

by | Dec 18, 2017 | DOT and Non DOT, Employee Health Management, Pre Employment Testing, Workplace Safety

Did you hear the news? Significant changes are being made to the urine drug testing panel, effective January 1, 2018.

The Department of Transportation (DOT) published a final rule in the Federal Register (82 FR 52229), adding four semi-synthetic opioids and methylenedioxyamphetamine (MDA) as an initial test analyte. It removed the testing for methylenedioxyethylamphetaime (MDEA).

Semi-Synthetic Opioids Added

The four semi-synthetic opioids added include: hydrocodone, oxycodone, hydromorphone, oxymorphone. Common names for these semi-synthetic opioids include OxyContin®, Percodan®, Percocet®, Vicodin®, Lortab®, Norco®, Dilaudid®, Exalgo®.


Applicable Testing

Such mandates will apply to all United States Department of Transportation Regulated employers.

  • FAA
  • FTA
  • USCG
  • FRA


Employee Medical Management

Is your organization prepared for the testing changes? Axiom OHP provides complete employee health medical management for your entire workforce, streamlining testing procedures based on the job classifications within your organization. Our unique platform compiles employee data into one easily accessible location so you can quickly view each employee’s status, exam results, and query compliance information.



Considering a COVID-19 employee vaccination program? What options are available? And how to get started.

Here’s what you need to know.